HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Necrobiotic xanthogranuloma without monoclonal gammopathy and with a rapidly fatal outcome].

AbstractBACKGROUND:
Necrobiotic xanthogranuloma is an extremely rare form of histiocytosis that presents clinically as yellowish infiltrated plaques or nodules. Ocular involvement is seen in over 80% of cases. Histopathology reveals numerous xanthomous histiocytes and collagen necrobiosis. Benign monoclonal gammopathy associated with myeloma is found in 80% of patients, but the course is normally long, with 100% survival at 10 years.
CASE REPORT:
A 76-year-old man presented skin lesions that subsequently became ulcerated. The clinical appearance and histopathological examination resulted in diagnosis of necrobiotic xanthogranuloma. No monoclonal gammopathy or myeloma was seen. The disease was marked by sensitivity to corticosteroids with failure of other therapies (cyclophosphamide, alpha interferon), onset ofcorticosteroid dependency, iatrogenic Cushing's syndrome and diabetes, which were in part responsible for the infectious complications and subsequent death of the patient.
DISCUSSION:
Necrobiotic xanthogranuloma is difficult to treat, even in the absence of myeloma or monoclonal gammopathy. Corticosteroids are probably the most efficacious treatment, but can give rise to multiple complications, resulting in this particular case in death of the patient.
AuthorsA Bernez, M Abdallah-Lotf, M D'Incan, A De Muret, P Souteyrand, G Lorette, L Machet
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 133 Issue 3 Pg. 246-9 (Mar 2006) ISSN: 0151-9638 [Print] France
Vernacular TitleXanthogranulome nécrobiotique sans gammapathie monoclonale d'évolution rapidement fatale.
PMID16800175 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Aged
  • Fatal Outcome
  • Granuloma (diagnosis)
  • Humans
  • Male
  • Necrobiotic Disorders (diagnosis)
  • Shock, Septic (etiology)
  • Ulcer (etiology)
  • Xanthomatosis (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: